FDA Supplement Label Compliance for Gummy Manufacturers: What Your Label Must Get Right

Why Gummy Supplement Labels Are a Distinct Compliance Challenge

If you've been applying the same label review checklist you'd use for a softgel or tablet, you're already behind. Gummy supplements introduce a set of manufacturing variables — moisture migration, bloom strength shifts, sugar coating weight gain, and depositing temperature fluctuations — that directly affect the accuracy of what's printed on your label. FDA doesn't grade on a curve for gummies, and 483 observations related to label accuracy are among the most cited findings in dietary supplement inspections under 21 CFR Part 111.

The core issue is that gummies are a living matrix. A batch deposited at 88°C and aged 24 hours will have a different moisture content — and therefore a different weight per unit — than one aged 48 hours in a room with 10% higher relative humidity. Because potency is typically expressed per gummy (e.g., "500 mg Vitamin C per gummy"), any weight deviation caused by moisture loss or gain creates a label accuracy problem. Your label compliance process must be engineered to account for these variables, not ignore them.

This guide is written specifically for U.S.-based gummy supplement manufacturers operating under 21 CFR Part 111. Whether you run a mogul line, a starch-free silicone mold system, or a continuous depositing operation, the labeling obligations are the same — and the consequences of getting them wrong include warning letters, import alerts, market withdrawals, and delistings from major retailers like Amazon, which enforces its own supplement compliance requirements layered on top of FDA's.

Required Label Elements Under 21 CFR Part 101 and Part 111

Every dietary supplement label — gummy or otherwise — must carry a defined set of mandatory elements. FDA's primary labeling regulation for dietary supplements is 21 CFR Part 101, which covers food labeling broadly, while Part 111 governs GMP compliance including label issuance, reconciliation, and batch record documentation. Understanding which regulation governs which element is essential for building a compliant label program.

The following elements are required on every gummy supplement label sold in the United States:

• Statement of identity: Must identify the product as a "dietary supplement" and can include a descriptor such as "Gummy Dietary Supplement." This must appear on the principal display panel (PDP).
• Net quantity of contents: Must reflect the actual number of gummies in the container. For gummies, this is where coating weight gain becomes critical — if your mogul-deposited gummies pick up 8–12% additional weight during sugar sanding or coating, your piece count and net weight must reflect finished product weight, not base gummy weight.
• Supplement Facts panel: Must list serving size in units consumers actually use ("2 gummies"), servings per container, calories, and all ingredients with Daily Values where established. Gummy manufacturers frequently err by calculating potency off the formula theoretical yield rather than finished product analytical results.
• Ingredient list: All ingredients in descending order of predominance by weight. For gummies, this commonly includes gelatin or pectin, glucose syrup, sucrose, citric acid, natural flavors, coloring agents, and carnauba wax. Each must be declared by its common or usual name.
• Name and place of business: Manufacturer, packer, or distributor name and full domestic address must appear on the label.
• Directions for use: Required when the product is for a use that requires direction. For gummies marketed to adults, "Take 2 gummies daily" is standard.
• Warnings and cautions: Including the iron warning if applicable, "Keep out of reach of children," and any structure/function claim disclaimer: "This statement has not been evaluated by the Food and Drug Administration."

Under 21 CFR Part 111, Subpart G, your facility must also maintain label issuance records, reconcile labels used versus labels destroyed, and ensure that only approved labels are released for use. A deviation in label reconciliation — even if the label itself is accurate — can trigger a 483 observation. Build your label control SOP to address these procedural requirements explicitly.

Gummy-Specific Potency and Serving Size Accuracy Issues

This is where most gummy manufacturers run into trouble. Because gummies are a water-containing matrix — whether you're working with a gelatin-based formula at 17–20% moisture or a pectin-based vegan gummy at slightly higher moisture — the declared potency per serving must be validated against finished product that has gone through your full manufacturing process: cooking, depositing, demolding, drying, tumbling, and coating.

Consider a common scenario: your R&D team develops a 500 mg Vitamin C gummy formula and validates potency at the lab scale. But at production scale, your mogul system deposits at a slightly higher temperature, driving off additional moisture during the first 12 hours of setting. Your finished piece weight drops from 4.2 g to 3.9 g. If Vitamin C was formulated as a percentage of total mass, that 7% weight loss translates to a 7% potency reduction — meaning your label claim of 500 mg is no longer supported. Under 21 CFR Part 111.75, you are required to verify that your dietary supplement meets its specifications before distribution. Shipping underpotent product is a GMP violation and a misbranding risk under Section 403 of the FD&C Act.

Practical steps to control gummy potency accuracy include:

1. Establish finished piece weight specifications after coating and packaging — not at the depositing stage. Set upper and lower control limits and track Cpk across batches.
2. Overformulate with validated overage for labile nutrients (Vitamin C, B vitamins, Vitamin D3) that degrade during cooking. Document the scientific basis for every overage in your Master Manufacturing Record (MMR).
3. Conduct end-of-shelf-life stability studies under ICH conditions or your product's intended storage conditions. Gummies with high water activity can accelerate nutrient degradation. Your label potency claim must be supported at expiration, not just at release.
4. Monitor water activity (Aw) as a routine in-process and release parameter. Target Aw values below 0.60 for shelf-stable gummies. Deviations affect both microbial safety and nutrient stability — both of which have label compliance implications.
5. Revalidate after any formula change — including switching from gelatin to pectin, changing a syrup supplier, or adjusting the cooking profile. These changes affect moisture equilibrium and can shift finished piece weight enough to invalidate your existing label claim.

Serving size accuracy deserves equal attention. If your label states "Serving Size: 2 Gummies" and your Supplement Facts panel declares nutrients per serving, a 10% variation in piece weight across a batch means some consumers are getting 10% more or less than declared. Under FDA's compliance policy for dietary supplements, a label potency claim must be met at the serving level. NSF GMP certification auditors routinely flag serving size validation as a gap in gummy manufacturer QA programs.

Coating, Coloring, and Allergen Declarations on Gummy Labels

The finishing steps in gummy manufacturing — tumbling with carnauba wax, sugar sanding, oil coating, or applying a hard-panned shell — all add ingredients that must appear on your label. This sounds straightforward, but coating lines introduce variability that can create labeling problems if your process is not tightly controlled.

Carnauba wax, beeswax, and shellac are all commonly used gummy finishing agents and each must be declared in the ingredient list. If you use beeswax, you may also need to consider consumer expectations around vegan certification — an increasingly important retail and Amazon listing requirement. Shellac carries a specific consumer disclosure issue because it is derived from the lac bug, which some consumers and certification bodies consider an animal-derived ingredient. Ingredient transparency on your label isn't just a regulatory obligation; it's a market access issue.

Coloring agents require careful attention. Natural colors (e.g., annatto, turmeric, beet juice concentrate, spirulina extract) must be declared by their common name. Synthetic colors certified by FDA (FD&C Red No. 40, FD&C Blue No. 1, etc.) must be declared by their specific name — "artificial color" alone is not sufficient under 21 CFR 101.22. Many gummy manufacturers switch color systems without updating their label review process, creating a misbranding situation where the ingredient list no longer matches the formula.

Allergen declarations are non-negotiable. The Food Allergen Labeling and Consumer Protection Act (FALCPA) and the more recent addition of sesame under FASTER Act of 2021 require that the nine major allergens — milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame — be declared either within the ingredient list or in a separate "Contains" statement. For gummy manufacturers, the most common allergen risks come from:

• Gelatin sourced from pork or beef (not a FALCPA allergen, but relevant for religious dietary compliance and label transparency)
• Tree nut or peanut flavoring components
• Wheat-derived glucose syrup (glucose syrup derived from wheat must be declared as containing wheat unless the manufacturer can demonstrate it is highly refined and meets the gluten-free threshold)
• Soy-derived ingredients in coating or flavoring systems
• Milk derivatives in some coating formulations

Run a full allergen risk assessment on every ingredient in your gummy formula — including processing aids and coating components — before finalizing your label. Update this assessment every time a supplier changes their formulation, even if your ingredient name on the purchase order stays the same.

Label Review, Approval, and Control Procedures Under 21 CFR Part 111

Having a compliant label is only half the requirement. Under 21 CFR Part 111, Subpart B, you must have written procedures governing how labels are designed, approved, stored, issued, and reconciled. FDA investigators inspecting gummy facilities will ask to see your label control SOP, your batch records showing label issuance and reconciliation, and your change control procedure for label revisions. Gaps in any of these areas are independent GMP violations, even if the label text itself is accurate.

Your label review and approval process should include the following key controls:

• Qualified reviewer sign-off: At least one qualified individual — typically your QA manager or a contracted regulatory affairs professional — must review and approve every label before first use and after any revision. Document the review with name, date, and scope of review.
• Label specification records: Maintain a label specification for each SKU that includes the approved artwork file, version number, and a list of all required elements verified during review. This becomes your master reference for batch record label reconciliation.
• Change control for label revisions: Any change to label text, format, or claims must go through a formal change control process. This includes ingredient list updates triggered by formula changes, serving size revisions driven by piece weight revalidation, and claim additions or deletions. Document the regulatory basis for each change.
• Label issuance and reconciliation at batch level: Your batch production record must show how many labels were issued, how many were used, and how many were destroyed. Unexplained label discrepancies are a 483 trigger. For gummy batches, account for labels used during line setup, printing trials, and reject units.
• Label storage controls: Obsolete labels must be physically segregated or destroyed immediately upon supersession. Gummy contract manufacturers working with multiple brand clients are especially at risk for label mix-ups if storage and issuance controls are inadequate.

For manufacturers seeking or maintaining NSF GMP certification, label control is audited as a formal program element. NSF auditors will trace a finished product batch back through label issuance, compare the label used against the approved specification, and verify that any prior label version was formally obsoleted. Building this traceability into your batch record template from the start is far more efficient than reconstructing it during an audit.

Amazon's supplement compliance requirements add another layer. As of current enforcement, Amazon requires that supplement labels meet FDA requirements and may request Certificates of Analysis, lab test results, or third-party certification documentation to verify label claims. Gummy products with potency claims that cannot be substantiated by recent finished product testing are at elevated risk for listing suspension. Maintaining current, product-specific CoAs from an ISO 17025-accredited laboratory is your best defense — and also good GMP practice regardless of your sales channel.

Label compliance for gummy supplements is not a one-time event. It is an ongoing program that must keep pace with formula changes, supplier changes, regulatory updates, and the inherent variability of your gummy manufacturing process. Build your label control infrastructure to be dynamic, documented, and defensible — and you'll be prepared whether the next challenge comes from an FDA inspector, an NSF auditor, or an Amazon compliance review.